Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gisela Mueller, MD, University of Michigan
ClinicalTrials.gov Identifier:
NCT00721929
First received: July 23, 2008
Last updated: December 4, 2012
Last verified: December 2012

July 23, 2008
December 4, 2012
October 2003
July 2010   (final data collection date for primary outcome measure)
Diagnosis of either benign or malignant adrenal mass on pathology [ Time Frame: 0-6 months ] [ Designated as safety issue: No ]
definitive diagnosis of adrenal mass
Not Provided
Complete list of historical versions of study NCT00721929 on ClinicalTrials.gov Archive Site
stability of growth of mass on follow up imaging [ Time Frame: 3-24 months ] [ Designated as safety issue: No ]
evidence for benign or malignant mass based on assessment of stability or growth
Not Provided
Not Provided
Not Provided
 
Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI
Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI

The purpose of this study is to determine if certain MRI sequences can accurately diagnose adrenal masses of unknown origin.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Adrenal Gland Disease
Procedure: MRI
Magnetic Resonance Imaging
Experimental: adrenal mass group
Intervention: Procedure: MRI
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
July 2012
July 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients can participate in this study if they are 18 years of age or older and if they have had a Cat Scan (CT scan) performed with and without contrast media (medication given intravenously to enhance the CT images) or if patients are scheduled to have a CT scan performed and if the reason their physician ordered the CT is because they have an adrenal mass of an unknown type.

Exclusion Criteria:

  • Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
  • Pregnant patients or patients who are lactating.
  • A patient who is claustrophobic and would require sedation to complete the MRI exam.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00721929
2003-0148
Not Provided
Gisela Mueller, MD, University of Michigan
University of Michigan
Not Provided
Not Provided
University of Michigan
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP